DigestivePathJC (@GIPathJC) header
DigestivePathJC (@GIPathJC) profile picture

Online Journal Club for gastrointestinal, hepatobiliary and pancreatic pathology #GIPathJC by Pallavi A. Patil @PAPatilMD

Joined August 2020
Photo by DigestivePathJC (@GIPathJC)Photo by DigestivePathJC (@GIPathJC)Photo by DigestivePathJC (@GIPathJC)Photo by DigestivePathJC (@GIPathJC)Photo by DigestivePathJC (@GIPathJC)Photo by DigestivePathJC (@GIPathJC)Photo by DigestivePathJC (@GIPathJC)Photo by DigestivePathJC (@GIPathJC)Photo by DigestivePathJC (@GIPathJC)Photo by DigestivePathJC (@GIPathJC)
Liver lesion. Chromogranin, synaptophysin, cytokeratin positive. Ki67 ~20%. Questions? #gipath #pathologist #pathology #liver
14
72
5
239
39,822
In challenging situations (hypermucinous epithelium without atypia), we often use a descriptive diagnosis, such as “hypermucinous features” or “hypermucinous epithelium.”
1
182
Replying to @GIPathJC
On superficial biopsy, nuclear atypia in hypermucinous dysplasia may not be obvious, as nuclear atypia is typically more prominent in the lower portion of crypts, and the degree of atypia tends to decrease towards the surface epithelium.
1
246
Unless there is a morphologically distinct area of hypermucinous epithelium accompanied by cytologic and/or architectural atypia (i.e., sharp transition from the normal colonic mucosa in the background), we do not typically make a definite diagnosis of hypermucinous dysplasia.
1
209
Colonic mucosa near ulceration and pseudopolyps can demonstrate hypermucinous epithelium, but there is no significant cytologic and/or architectural atypia in that setting.
1
240
Replying to @GIPathJC
@GIPathJC #pathtwitter #gipath is on December 20 at 8:30 pm EST!Article on dysplasia in inflammatory bowel disease @Histo_Journal pubmed.ncbi.nlm.nih.gov/3548… With @DorukBahceci @UCSF Join at #GIPathJC in Twitter search box. Make sure to tag all questions and comments with #GIPathJC
Save the date for @GIPathJC on December 20 at 8:30 pm EST. We will discuss dysplasia in inflammatory bowel disease, article from team @UCSF @MoffittNews in @Histo_Journal at pubmed.ncbi.nlm.nih.gov/3548… Author Dr. Bahceci will join us for discussion. Here on twitter at #GIPathJC
1
2
450
Save the date for @GIPathJC on December 20 at 8:30 pm EST. We will discuss dysplasia in inflammatory bowel disease, article from team @UCSF @MoffittNews in @Histo_Journal at pubmed.ncbi.nlm.nih.gov/3548… Author Dr. Bahceci will join us for discussion. Here on twitter at #GIPathJC
1
5
1
11
DigestivePathJC retweeted
Replying to @GIPathJC @BIDMCpath
Thanks #GIPathJC for having me and discussing our work!
1
2
7
DigestivePathJC retweeted
Replying to @Mvgs1706 @GIPathJC
For eg. Fig 4 in our paper shows a treated metasatic small cell ca which shows a low grade-ish morphology and patchy KI67 labeling...if it was not for the history which prompted Rb IHC, this could be mistaken for a mets WDNET #GIPathJC
2
5
DigestivePathJC retweeted
Replying to @ALBoothMD @GIPathJC
I hope they do, now we have published data!#GIPathJC
1
1
3
DigestivePathJC retweeted
Replying to @GIPathJC
Yes, it is really important to establish diagnosis on treatment naive sample #GIPathJC
1
2
4
DigestivePathJC retweeted
Replying to @Mvgs1706 @GIPathJC
Yes, this is really interesting. I recall Dr. Klimsta mentioning this at the USCAP @pbpath companion meeting
1
2
DigestivePathJC retweeted
Replying to @GIPathJC
This was the most interesting part as soem acses showed morphology resembling WDNETs or more ambiguous morphology...coupled with altered KI67, this can cause significant diagnostic issues
DigestivePathJC retweeted
Thats a great comment, Grace. But in reality, most of the pts died of disease
1
2
Replying to @GIPathJC
would be interesting to see long term clinical follow up and whether the degree of “downgrade” in Ki67 proliferative index in post-treated NENs portend to (+/-) prognostic implications #gipathjc @GIPathJC @Mvgs1706
1
1
5
Replying to @GIPathJC
what was the interrater reliability on Ki67 heterogeneity scoring between the authors-pathologists? #GIPathJC @GIPathJC
1
1
2
DigestivePathJC retweeted
Replying to @ALBoothMD @GIPathJC
I also mentioned this caveat during my presentation @NANETS1 last year #GIPathJC
1
3
DigestivePathJC retweeted
Replying to @GIPathJC
In our small cohort, the findings hold true for NECs of various body sites #GIPathJC
3
3
DigestivePathJC retweeted
Replying to @Mvgs1706 @GIPathJC
Do the oncologists know this? #gipathjc
4
1
2
DigestivePathJC retweeted
Replying to @GIPathJC
This can create a significant classification issue with interpretation if a treated sample is used for primary diagnosis #GIPathJC
1
1
1